M Navarro

1.1k total citations
40 papers, 624 citations indexed

About

M Navarro is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Oncology. According to data from OpenAlex, M Navarro has authored 40 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 11 papers in Genetics and 11 papers in Oncology. Recurrent topics in M Navarro's work include Brain Metastases and Treatment (9 papers), Glioma Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (5 papers). M Navarro is often cited by papers focused on Brain Metastases and Treatment (9 papers), Glioma Diagnosis and Treatment (8 papers) and Lung Cancer Research Studies (5 papers). M Navarro collaborates with scholars based in Spain, Chile and Palestinian Territory. M Navarro's co-authors include Celia Requena, Maria Martinez‐García, Adolfo Aliaga, J.J. Vilata, Vicente Sabater, Juan Jesús Cruz, Antonio Hernández Martínez, Luís Requena, R. Botella and Alejandro Martı́n and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and The Annals of Thoracic Surgery.

In The Last Decade

M Navarro

37 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Navarro Spain 13 170 134 128 117 113 40 624
D. Fırat Türkiye 14 130 0.8× 192 1.4× 83 0.6× 52 0.4× 53 0.5× 46 680
Florence Ida Hsu United States 11 100 0.6× 119 0.9× 133 1.0× 156 1.3× 77 0.7× 26 985
Elena Pérez‐Ceballos Spain 13 63 0.4× 107 0.8× 180 1.4× 56 0.5× 28 0.2× 25 578
Masahito Tsurusawa Japan 22 162 1.0× 317 2.4× 139 1.1× 21 0.2× 79 0.7× 90 1.2k
Byung Soo Kim South Korea 18 88 0.5× 334 2.5× 105 0.8× 37 0.3× 56 0.5× 70 816
Carlos Chiattone Brazil 22 59 0.3× 278 2.1× 503 3.9× 69 0.6× 70 0.6× 99 1.1k
Umihiko Sawada Japan 14 74 0.4× 258 1.9× 112 0.9× 26 0.2× 55 0.5× 77 691
O Hartmann France 16 137 0.8× 167 1.2× 61 0.5× 14 0.1× 110 1.0× 40 668
D. Lokanatha India 14 196 1.2× 401 3.0× 69 0.5× 25 0.2× 90 0.8× 71 806
A. Loverre Italy 6 68 0.4× 474 3.5× 62 0.5× 33 0.3× 202 1.8× 7 906

Countries citing papers authored by M Navarro

Since Specialization
Citations

This map shows the geographic impact of M Navarro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Navarro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Navarro more than expected).

Fields of papers citing papers by M Navarro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Navarro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Navarro. The network helps show where M Navarro may publish in the future.

Co-authorship network of co-authors of M Navarro

This figure shows the co-authorship network connecting the top 25 collaborators of M Navarro. A scholar is included among the top collaborators of M Navarro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Navarro. M Navarro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sepúlveda-Sánchez, Juan Manuel, Maria Martinez‐García, P. Foro, et al.. (2024). 454P Tetrahydrocannabinol (THC) / cannabidiol (CBD) oral solution in combination with temozolomide (TMZ) and radiotherapy (RT) in patients with newly diagnosed glioblastoma: Phase Ib GEINO-1601 trial. Annals of Oncology. 35. S411–S411. 1 indexed citations
2.
Alonso‐Gordoa, Teresa, Paula Jiménez‐Fonseca, Javier Martínez‐Trufero, et al.. (2024). SEOM-GETNE-TTCC Clinical guideline thyroid cancer (2023). Clinical & Translational Oncology. 26(11). 2902–2916. 1 indexed citations
3.
Navarro, Paloma, Carmen Beato, Juan Francisco Rodríguez-Moreno, et al.. (2024). Prospective study of the real impact of fusion centered genomic assays in patient management in a national collaborative group: the GETHI-XX-16 study. Clinical & Translational Oncology. 27(6). 2719–2730.
4.
Pérez‐Segura, Pedro, et al.. (2023). SEOM-GEINO clinical guidelines for high-grade gliomas of adulthood (2022). Clinical & Translational Oncology. 25(9). 2634–2646. 13 indexed citations
5.
Navarro, M, et al.. (2023). Cerebellar Hemangioblastoma with Leptomeningeal Spread and a Fatal Outcome: A Rare Case Report with MDM2 and EGFR Alterations. International Medical Case Reports Journal. Volume 16. 709–714.
6.
Rincon, Leonardo Mejia, Marcelo Sanmartı́n, Gonzalo Luis Alonso Salinas, et al.. (2019). A genetic risk score predicts recurrent events after myocardial infarction in young adults. Revista Española de Cardiología (English Edition). 73(8). 623–631. 10 indexed citations
7.
8.
Navarro, M, et al.. (2018). Large cell neuroendocrine carcinoma of the lung with atypical evolution and a remarkable response to lutetium Lu 177 dotatate. Annals of Nuclear Medicine. 32(8). 568–572. 7 indexed citations
9.
Alonso, Sara, Emilia Pardal, M Navarro, et al.. (2017). Plitidepsin: design, development, and potential place in therapy. Drug Design Development and Therapy. Volume11. 253–264. 80 indexed citations
10.
Martinez‐García, Maria, Cristina Carrato, L. Ley, et al.. (2017). SEOM clinical guidelines for diagnosis and treatment of glioblastoma (2017). Clinical & Translational Oncology. 20(1). 22–28. 54 indexed citations
11.
Subirá, Dolores, Marta Simó, Cristina Serrano, et al.. (2015). Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis. Clinical & Experimental Metastasis. 32(4). 383–391. 45 indexed citations
12.
Andersson, Per, Steven Y. C. Tong, Rachael A. Lilliebridge, et al.. (2013). Multisite Direct Determination of the Potential for Environmental Contamination of Urine Samples Used for Diagnosis of Sexually Transmitted Infections. Journal of the Pediatric Infectious Diseases Society. 3(3). 189–196. 9 indexed citations
13.
Errando, C.L., et al.. (2012). Anesthetic management of a patient diagnosed with CADASIL (cerebral arteriopathy, autosomal dominant, with subcortical infarcts and leukoencephalopathy). Revista Española de Anestesiología y Reanimación. 59(2). 102–106. 1 indexed citations
14.
Subirá, Dolores, Cristina Serrano, Susana Castañón, et al.. (2011). Role of flow cytometry immunophenotyping in the diagnosis of leptomeningeal carcinomatosis. Neuro-Oncology. 14(1). 43–52. 41 indexed citations
15.
Navarro, M, Alberto Ocaña, Óscar Blanco, et al.. (2008). Third Nerve Palsy as the Initial Presenting Sign of Metastatic Prostate Cancer. American Journal of Clinical Oncology. 31(4). 407–408. 3 indexed citations
16.
Cruz, Juan Jesús, Alberto Ocaña, M Navarro, E. del Barco, & Emilio Fonseca. (2008). New options in the treatment of locally advanced head and neck cancer: Role for induction chemotherapy. Cancer Treatment Reviews. 34(3). 268–274. 14 indexed citations
17.
Navarro, M, et al.. (2005). Patient with disseminated intravascular coagulation as the first manifestation of adenocarcinoma of the prostate. Risks of prostatic biopsy. Prostate Cancer and Prostatic Diseases. 9(2). 190–191. 12 indexed citations
18.
Navarro, M, et al.. (2002). Dermatofibrosarcoma protuberans with onset in early childhood: a case report. Journal of the European Academy of Dermatology and Venereology. 16(2). 154–155. 10 indexed citations
19.
Requena, Celia, M Navarro, Antonio Hernández Martínez, et al.. (2001). Adverse Reactions to Injectable Aesthetic Microimplants. American Journal of Dermatopathology. 23(3). 197–202. 126 indexed citations
20.
Linares, Mariano, et al.. (1989). Idiopathic myelofibrosis terminating in erythroleukemia. American Journal of Hematology. 32(1). 70–71. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by D. Fırat Breakdown of academic impact, for papers by Florence Ida Hsu Breakdown of academic impact, for papers by Elena Pérez‐Ceballos Breakdown of academic impact, for papers by Masahito Tsurusawa Breakdown of academic impact, for papers by Byung Soo Kim Breakdown of academic impact, for papers by Carlos Chiattone Breakdown of academic impact, for papers by Umihiko Sawada Breakdown of academic impact, for papers by O Hartmann Breakdown of academic impact, for papers by D. Lokanatha Breakdown of academic impact, for papers by A. Loverre
Rankless by CCL
2026